Company Analysis
Sign in

VivoSim Labs, Inc. (VIVS)

Nasdaq: VIVS · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2010
Full chart Alerts Compare
Grade3.3
◀ Past 1.7● Present 2.7▶ Future 4.8
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

31 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to VivoSim Labs, Inc.’s names, not what it holds today.

Patents granted
31
31 utility, 1976 to Dec 31, 2025
Granted in 2025
4
Against 3 in 2024 and 5 in 2023
Applications published
55
since 2001, to Dec 31, 2025
Names they are printed under
2
a subsidiary
By yearGrantedApplications published
'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Analysis of biological materials5
Other special machines5
Medical technology3
Biotechnology2
Pharmaceuticals2
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
ORGANOVO, INC. a subsidiary
US, as the owner printed on each patent
31 granted
18 published
Organovo, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
37 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 12, 202512,384,098Three-dimensional bioprinterOther special machinesORGANOVO, INC.
Jul 29, 202512,372,515Engineered tissues for in vitro research uses, arrays thereof, and methods of making the sameMedical technologyORGANOVO, INC.
Jul 22, 202512,365,877Engineered intestinal tissue and uses thereofPharmaceuticalsORGANOVO, INC.
Mar 18, 202512,252,712Use of engineered liver tissue constructs for modeling liver disordersAnalysis of biological materialsORGANOVO, INC.
Jul 16, 202412,037,603Methods for tissue fabricationBiotechnologyORGANOVO, INC.
May 14, 202411,982,668Use of engineered renal tissues in assaysAnalysis of biological materialsORGANOVO, INC.
Jan 9, 202411,867,689Engineered renal tissues, arrays thereof, and methods of making the sameAnalysis of biological materialsORGANOVO, INC.
Dec 26, 202311,850,330Bioprinted hair follicles and uses thereofMedical technologyORGANOVO, INC.
Oct 3, 202311,773,094Farnesoid X receptor agonists and uses thereofOrganic fine chemistryORGANOVO, INC.
May 23, 202311,655,456Engineered intestinal tissue and uses thereofPharmaceuticalsORGANOVO, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jul 11, 20242024/0226386BIOPRINTED HAIR FOLLICLES AND USES THEREOFMedical technologyOrganovo, Inc.
May 23, 20242024/0168010Engineered Three-Dimensional Breast Tissue, Adipose Tissue, and Tumor Disease ModelBiotechnologyOrganovo, Inc.
Nov 30, 20232023/0382913FARNESOID X RECEPTOR AGONISTS AND USES THEREOFOrganic fine chemistryOrganovo, Inc.
Oct 12, 20232023/0320837Multilayered Vascular TubesMedical technologyOrganovo, Inc.
Jun 29, 20232023/0201420Engineered Three-Dimensional Skin Tissues, Arrays Thereof, and Methods of Making the SameMedical technologyOrganovo, Inc.
Jul 21, 20222022/0229045Use of Engineered Renal Tissues in AssaysAnalysis of biological materialsORGANOVO, INC. · patent 11,982,668 granted from it
Jun 30, 20222022/0204942Engineered Intestinal Tissue and Uses ThereofPharmaceuticalsOrganovo, Inc.
Jun 30, 20222022/0204941Engineered Intestinal Tissue and Uses ThereofPharmaceuticalsOrganovo, Inc. · patent 12,365,877 granted from it
Jun 23, 20222022/0195380METHODS FOR TISSUE FABRICATIONBiotechnologyOrganovo, Inc. · patent 12,037,603 granted from it
Jan 13, 20222022/0009158DEVICES, SYSTEMS, AND METHODS FOR THE FABRICATION OF TISSUEOther special machinesORGANOVO, INC. · patent 11,413,805 granted from it
What it applied for, 2024 to 2025: Biotechnology 1 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton VIVS · research, not advice